Poland· PL-100002042

Bromocorn

A bromocriptine product containing bromocriptinum, registered in Poland by Farmaceutyczna Spółdzielnia Pracy FILOFARM. The same ATC class is registered in 9 of our 19 countries.

ATC G02CB01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedBromocornATCG02CB01REGISTER NO.PL-100002042PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Bromocriptine is registered in 9 of 19 countries.

Countries holding a registration under ATC G02CB01 (bromocriptine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose

Bromocriptine · ATC G02CB01

9 / 19 countries

  • Czechiaprice
  • Finlandprice
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of bromocriptine costs, country by country.

Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.54 in Italy to $3.22 in United States — a ×5.9 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Bromocriptine · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • US United States$3.22 (acquisition cost)
  • CH Switzerland$2.09
  • IT Italy$0.54
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Bromocriptinum
Manufacturer
Farmaceutyczna Spółdzielnia Pracy FILOFARM
Country
Poland (PL)
ATC code
G02CB01
ATC class
Bromocriptine
Defined daily dose
5 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

1 priced
  • gtin
    05909990211913
    30 szt.
    PLN 18.9

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

92 interactions on record for bromocriptine.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Bromocriptine · interactions on record

92 records

  • 3 severe
  • 87 moderate
  • 2 minor

Most severe, free to view

  • IsomethepteneA03AX10severe
  • LorcaserinA08AA11severe
  • PhenylpropanolaminA08AA13severe
  • LansoprazoleA02BC03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Bromocriptine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bromocriptine products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Belgium · Parlodel
  • Bulgaria · Бромокриптин Медокеми
  • Cyprus · Medocriptine, Pirodal
  • Czechia · Medocriptine
  • Germany · Pravidel
  • Estonia · Bromocriptin Richter
  • Spain · Parlodel
  • France · Parlodel
  • United Kingdom (Northern Ireland) · Bromocriptine, Bromocriptine Brown & Burk Uk
  • Hungary · Bromocriptin Richter
  • Italy · Parlodel
  • Lithuania · Bromocriptin Richter
  • Luxembourg · Pravidel
  • Latvia · Bromocriptin Richter
  • Malta · Medocriptine
  • Netherlands · Parlodel
  • Norway · Parlodel
  • Portugal · Bromocriptina Generis, Parlodel
  • Romania · Brocriptin
  • Sweden · Pravidel
  • Slovakia · Medocriptine

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a982ae7d-bd34-4610-b485-d6344e8d172b
GET /v1/drugs/a982ae7d-bd34-4610-b485-d6344e8d172b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "2,5 mg",
  "packaging": "05909990211913 ¦ Rp ¦ 2120\n30 tabl.",
  "substance": "Bromocriptini mesylas 2.87 mg",
  "common_name": "Bromocriptinum",
  "pl_product_id": "100002042",
  "pozwolenie_nr": "02119",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about bromocriptine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.